dihydro-beta-erythroidine has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gan, Y; Kousari, A; La Cava, A; Liu, Q; Shi, FD; Tang, Z; Wu, W | 1 |
| Cano, A; Domercq, M; Gómez-Vallejo, V; Higuchi, M; Llop, J; Martín, A; Matute, C; Muñoz, C; Padro, D; Szczupak, B | 1 |
2 other study(ies) available for dihydro-beta-erythroidine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Genetic deficiency of β2-containing nicotinic receptors attenuates brain injury in ischemic stroke.
Topics: Action Potentials; Animals; Brain Injuries; Cells, Cultured; Cerebral Cortex; Dihydro-beta-Erythroidine; Disease Models, Animal; Glucose; Hypoxia; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Magnetic Resonance Imaging; Male; Mice; Mice, Knockout; Neurologic Examination; Neuroprotective Agents; Receptors, Nicotinic; Time Factors | 2014 |
In vivo PET imaging of the α4β2 nicotinic acetylcholine receptor as a marker for brain inflammation after cerebral ischemia.
Topics: Amides; Animals; Brain; CD11b Antigen; Cell Count; Dihydro-beta-Erythroidine; Disease Models, Animal; Encephalitis; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Infarction, Middle Cerebral Artery; Isoquinolines; Magnetic Resonance Imaging; Male; Mental Disorders; Positron-Emission Tomography; Protein Binding; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Time Factors | 2015 |